BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Eledon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-31 5:50 pm Unchanged | 2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 6,293,282 10.500% | 0 (Unchanged) | Filing |
| 2024-10-31 5:49 pm Purchase | 2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 6,293,282 15.900% | 1,966,572 (+45.45%) | Filing |
| 2024-02-14 10:06 am Purchase | 2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 4,326,710 17.900% | 2,000,000 (+85.96%) | Filing |
| 2022-01-28 4:35 pm Purchase | 2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% | 878,690 (+60.68%) | Filing |
| 2022-01-10 5:57 pm Purchase | 2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% | 13,088 (+0.91%) | Filing |
| 2022-01-10 5:51 pm Purchase | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% | 1,434,932 (New Position) | Filing |